We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Dr
Elena
Ratschen
+44 (0)1904 320000
elena.ratschen@york.ac.uk
Dr
Yan
Ding
+44 (0)1904 32 5600
yan.ding@york.ac.uk
Prof
Lion
Shahab
+44 (0)20 7679 1805
lion.shahab@ucl.ac.uk
Smoking cessation using an e-cigarette in patients living in the community who have a mental illness
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
Tobacco smoking is the single largest contributor to health inequalities for people with mental illness (PWMI). Developing and implementing ways to address this widening health gap has been identified as a priority in the NHS Long Term Plan and the 2019 Tobacco Control Plan for England. E-cigarettes have been suggested as a potentially particularly helpful way to support people with mental illness quit smoking or substantially reduce consumption. However, there have been no fully powered trials to assess this potential. The researchers completed a feasibility study in January 2023 and are now ready to proceed to a full randomised controlled trial (RCT). The aim of this study is to assess the effectiveness and cost-effectiveness of providing an e-cigarette starter kit to PWMI treated in the community to aid smoking cessation and harm reduction.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
You can take part if:
You may not be able to take part if:
1. Patients must not have had an inpatient admission in the last 3 months 2. Smokers who are currently using e-cigarettes regularly (at least weekly)3. Patients who are participating in other smoking cessation trials4. Patients who are receiving treatment for drug or alcohol use5. Patients who have a diagnosis of Alzheimer’s disease or dementia6. Patients who are pregnant or breastfeeding
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
Dr
Yan
Ding
+44 (0)1904 32 5600
yan.ding@york.ac.uk
Prof
Lion
Shahab
+44 (0)20 7679 1805
lion.shahab@ucl.ac.uk
Dr
Elena
Ratschen
+44 (0)1904 320000
elena.ratschen@york.ac.uk
The study is sponsored by University of York and funded by Yorkshire Cancer Research.
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Or CPMS 58155
You can print or share the study information with your GP/healthcare provider or contact the research team directly.